What Kennedy’s Confirmation as Health Secretary Could Mean for Food M&A
As criticism against ultra-processed foods grows, strategic and PE food investors could be impacted differently, says Balmoral Advisors’ Bob Dekker
Policy Updates
All Eyes on the Presidential Race
M&A experts weigh in on how election outcomes might impact dealmaking in the months ahead
How Private Equity Can Respond to Foreign Investment Risks
In light of recent warnings on the risks of foreign investments, PE and VC firms must remain vigilant and proactive in safeguarding the sensitive information of their portfolio companies
What’s Next for PE Firms: An SEC Update
Emilie Abate of Iron Road Partners shares her insights into how regulation of the private equity space is shaping up
Healthcare Private Equity Investors Tackle Regulatory Challenges
How private equity investors active in the healthcare industry are responding to government inquiries on rollups
New Merger Guidelines Increase Risks for PE, Mid-Market Deals
PE firms should not assume that a transaction will fly under the radar simply because of a relatively low value
For Private Equity, the New Year Rings in New Regulatory Pressures
As dealmakers look to 2024, there is a host of new rules or proposed rules that private equity firms need to either adhere to or keep a close eye on
Investing in Ideals: A Conversation with Penny Pritzker
Penny Pritzker joins GrowthTV to discuss how she navigates the unique challenges of 2023
Wading Through the Data of M&A Forecasts
We combed through industry research and talked to three experts to get the skinny on what PE can expect for dealmaking this year